MedTrace Logo

Hydration During Thoracic Surgery

NCT04817722 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 222

Last updated 2021-03-26

No results posted yet for this study

Summary

The purpose of this retrospective study was to analyze the role of intraoperative crystalloid administration on postoperative hospital length of stay and on the incidence of previously reported adverse events following thoracic surgery.

Conditions

  • Hospital Length of Stay; Adverse Events

Interventions

DRUG

Intravenous Solution

Intraoperative hydration

Sponsors & Collaborators

  • Ochsner Health System

    lead OTHER

Principal Investigators

  • Bobby D Nossaman, MD · Ochsner Health System

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-12-12
Primary Completion
2016-01-31
Completion
2016-06-01
FDA Drug
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04817722 on ClinicalTrials.gov